RecruitingPhase 2NCT04343157

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases: Avoidance of Eloquent White Matter and Hippocampal Regions


Sponsor

Jona Hattangadi-Gluth

Enrollment

60 participants

Start Date

May 1, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS, and analyze biomarkers of radiation response. This work will advance the investigators' understanding of neurocognitive changes after brain SRS and help create interventions that preserve cognitive-function in brain metastases patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a precision radiation treatment for people with cancer that has spread to the brain (brain metastases). The technique — called image-guided, cognitive-sparing radiosurgery — targets tumors with high-dose radiation while deliberately avoiding areas of the brain responsible for memory and thinking, to help protect cognitive function. **You may be eligible if:** - You are 18 years or older - You have 1 to 3 brain metastases, each smaller than 3 cm - Your cancer originated from outside the brain (such as lung, breast, or prostate cancer) - You are in reasonably good health and can perform daily activities - Your life expectancy is greater than 6 months - You are able to undergo brain MRI scans - You can complete memory and thinking tests **You may NOT be eligible if:** - You are pregnant or nursing - You cannot have an MRI with contrast dye - The tumor is growing directly into brain areas that need to be protected - You are receiving chemotherapy on the same day as radiation - You have previously had whole-brain radiation therapy - Your cancer has spread to the lining of the brain (leptomeningeal disease) - Your cancer type is germ cell tumor, small cell carcinoma, or primary brain lymphoma Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONCognitive Sparing Brain Stereotactic Radiosurgery (SRS)

In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS, and analyze biomarkers of radiation response. This work will advance the investigators' understanding of neurocognitive changes after brain SRS and help create interventions that preserve cognitive-function in brain metastases patients.


Locations(1)

Moores Cancer Center

San Diego, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04343157


Related Trials